Search

everythinglearnresearchcommunity

for

Search:↓

Pegvaliase effectively reduces blood phenylalanine levels in most PKU patients, but requires personalized plans and good communication to manage side effects.

Topical PROTACs show promise for treating skin conditions but need better stability and delivery methods.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Nanoparticles can effectively treat diseases by modifying blood vessel growth.

The revised European Patent Convention may limit generic drug use, affecting healthcare professionals' treatment choices.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Quick, selective detection of tadalafil and finasteride in human plasma developed.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Minoxidil promotes hair growth by penetrating skin, with ethanol-containing formulas working best.

Minoxidil foam helps hair growth by increasing good proteins and decreasing bad pathways in men with hair loss.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

Multitarget drugs are needed to better treat complex diseases.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

Cacumen Platycladi extract can safely and effectively reduce hair loss and increase hair density.

Inhibiting PDE8A may help treat hair loss by boosting fat cell growth and hair regeneration.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Human hair-derived particles can effectively carry and release the cancer drug Paclitaxel in a pH-sensitive manner, potentially targeting cancer cells while sparing healthy ones.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.